Task Group Charge

To identify imaging technology needs and potential solutions (e.g., hardware, software or interoperability methods or procedures), and strategies to further their use and transition into all clinical points along the multi-disciplinary care pathway of lung cancer including lung cancer screening, early detection, diagnosis and management.

Leadership

Daniel C. Sullivan, MD

Task Group Chair
Duke Cancer Institute

Michael McNitt-Gray, PhD

Task Group Vice Chair
University of California, Los Angeles

Task Group Members

Denise Aberle, MD
University of California, Los Angeles (UCLA)

Samuel Armato, PhD
University of Chicago

Rick Avila, MS
Accumetra

Paul Bergstrom, PhD
National Institute of Standards and Technology

Maria Chong, PhD
RADIA Imaging (Seattle, Washington)

Dianna Cody, PhD
The University of Texas MD Anderson Cancer Center

Laura Coombs, PhD
American College of Radiology Data Science Institute

Richard Frank, MD, PhD
Siemens Healthineers North America

Robert Gillies, PhD
Moffitt Cancer Center

Jonathan Goldin, MD, PhD
UCLA

Jayashree Kalpathy-Cramer, PhD
Athinoula A. Martinos Center for Biomedical Imaging

Ella Kazerooni, MD, MS*
University of Michigan

Nicholas Petrick, PhD
FDA

David Yankelevitz, MD
Icahn School of Medicine at Mt. Sinai

(*) indicates Steering Committee member

Opportunities for Intervention/Influence:

  • Foster advances in imaging technology to improve sensitivity and specificity of cancer detection in lung cancer screened individuals
  • Improve protocols for screening and follow-up
  • Promote quality imaging facilities and providers